•
CN
CNTA
Centessa Pharmaceuticals plc American Depositary Shares
polygonPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
3.39B
Volume
6.46M
52W High
$30.58
52W Low
$9.60
Open
$23.00
Prev Close
$22.92
Day Range
22.59 - 23.55
About Centessa Pharmaceuticals plc American Depositary Shares
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
Latest News
Centessa Pharmaceuticals Announces Poster Presentation of New Preclinical Data Supporting Expansion of Orexin Receptor 2 (OX2R) Agonist Pipeline into Neuropsychiatric Indications at the 64th ACNP Annual Meeting
GlobeNewswire Inc.•Jan 14
Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying
The Motley Fool•Nov 17
Why Centessa Pharmaceuticals Stock Crushed the Market Today
The Motley Fool•Nov 12
Centessa Pharmaceuticals Announces Pricing of $250,000,000 Public Offering of American Depositary Shares
GlobeNewswire Inc.•Nov 12
Centessa Pharmaceuticals Announces Proposed Public Offering of American Depositary Shares
GlobeNewswire Inc.•Nov 11
Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2025
GlobeNewswire Inc.•Oct 31
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2025
GlobeNewswire Inc.•Aug 12
Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2025
GlobeNewswire Inc.•Aug 8